Retraction

Abstract

“Administration of MS‐275 Improves Cognitive Performance and Reduces Cell Death Following Traumatic Brain Injury in Rats” by P. Cao, Y. Liang, X. Gao, M.‐G. Zhao and G.‐B. Liang, CNS Neuroscience Therapeutics, 19:337–345. doi: 10.1111/cns.12082

The above article, published online on March 29, 2013 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the author(s), the journal's Editor in Chief, Professor Ding‐Feng Su, and John Wiley & Sons Ltd. The retraction has been agreed due to unattributed reuse of two figures from the following posters without permission from Dr Bruce G. Lyeth, Professor of Neuroscience in the University of California at Davis.

Poster 1: “Cognitive Effects of Repeated Mild Traumatic Brian Injury in Adult Rats” in the National Neurotrauma Society Conference 2011 in Santa Babara, CA, USA

Poster 2: “Repeated Post Injury Dosing with Amantadine Improves Cognitive Outcome after Fluid Percussion TBI in Rats” in the National Neurotrauma Society Conference 2012 in Phoenix, AZ, USA

Reference: Cao P, Liang Y, Gao X, Zhao M‐G, Liang G‐B. Administration of MS‐275 improves cognitive performance and reduces cell death following traumatic brain injury in rats. CNS Neurosci Ther 2013;19:337–345. doi: 10.1111/cns.12082